No Detail Found!

Role of coagulation profile in predicting fatal coagulopathies in carcinoma prostate.

Author(s)
Saeed Sattar Shaikh Isra University, Hyderabad, Sindh, Pakistan
Rashid Ahmed Memon Isra University, Hyderabad, Sindh, Pakistan
Naveed Sattar Shaikh Liaquat University of Medical and Health Sciences (LUMHS) Jamshoro, Sindh, Pakistan
Ghulam Shah Nizamani Isra University, Hyderabad, Sindh, Pakistan
Shumaila Shabir Shaikh Isra University, Hyderabad, Sindh, Pakistan
Kashif Rashid Shaikh Isra University, Hyderabad, Sindh, Pakistan
Abstract
OBJECTIVES: Recognition of fatal coagulopathies in patients with carcinoma of prostate by carrying out platelet count, PT and APTT. STUDY DESIGN: Case-control study. PLACE AND DURATION: Samples collected from patients attending ISRA University Hospital, Hyderabad, Liaquat University of Medical & Health Sciences Hospital Hyderabad and NIMRA Jamshoro from June 2011 to November 2011. Study was conducted in the Pathology department,ISRA University Hospital, Hyderabad. Duration of study was six months. METHODOLOGY: Cases were patients with prostatic carcinoma who were diagnosed on biopsy examination. Controls were normal healthy randomly selected age matched adult males from Hyderabad without prostatic carcinoma. A total of one hundred subjects were included in the study. They were divided in two groups as follows; Group - I: Patients - Diagnosed cases of carcinoma of prostate. Group - II: Control - Normal subjects of the same age group. RESULTS: A total number of 50 cases with the history of prostatic carcinoma were included according to the criteria mentioned in the material and method section. The frequencies of different variables were taken for platelet count, prothrombin time and activated partial thromboplastin time. In Group - I (Cases), the mean platelet count was 197.52 x 103 in patients with advance age and in Group - II (Controls), the mean platelet count was 286.06 x 103. The mean platelet count of cases and control is shown in Table - I. In the Group - I (Cases) the mean PT value was 16.95 seconds and in Group - II (Controls) the mean PT value was 11.92 seconds. The mean PT of cases and control is shown in Table - II. In the Group - I (Cases) the mean APTT value was 36.88 seconds and in Group - II (Controls) the mean APTT value was 30.94 seconds. The mean APTT of cases and control is shown in Table - III. CONCLUSION: Early analysis and recognition of coagulopathies in patients with carcinoma of prostate by carrying out platelet count, PT and APTT should be sorted out to help the patients in terms of treatment or diagnosis or prevention of fatal complications. Disseminated intravascular coagulation is the most frequently reported disorder but, in spite of its long-time recognition, its treatment remains controversial. Our results suggest that platelet count; PT and APTT are altered in patients with prostate cancer. Further study is needed to elucidate the underlying mechanism and clinicalsignificances of such a phenomenon among patients with prostate cancer.
Publication Details
Page(s) 1-4
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 5, Issue: 4, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

24

Views